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Abstract
Background: The frequency of drug prescription errors is high. Excluding errors in decision making, the
remaining are mainly due to order ambiguity, non standard nomenclature and writing illegibility. The aim
of this study is to analyse, as a part of a continuous quality improvement program, the quality of
prescriptions writing for antibiotics, in an Italian University Hospital as a risk factor for prescription errors.
Methods: The point prevalence survey, carried out in May 26–30 2008, involved 41 inpatient Units. Every
parenteral or oral antibiotic prescription was analysed for legibility (generic or brand drug name, dose,
frequency of administration) and completeness (generic or brand name, dose, frequency of administration,
route of administration, date of prescription and signature of the prescriber). Eight doctors (residents in
Hygiene and Preventive Medicine) and two pharmacists performed the survey by reviewing the clinical
records of medical, surgical or intensive care section inpatients. The antibiotics drug category was chosen
because its use is widespread in the setting considered.
Results: Out of 756 inpatients included in the study, 408 antibiotic prescriptions were found in 298
patients (mean prescriptions per patient 1.4; SD ± 0.6). Overall 92.7% (38/41) of the Units had at least one
patient with antibiotic prescription. Legibility was in compliance with 78.9% of generic or brand names,
69.4% of doses, 80.1% of frequency of administration, whereas completeness was fulfilled for 95.6% of
generic or brand names, 76.7% of doses, 83.6% of frequency of administration, 87% of routes of
administration, 43.9% of dates of prescription and 33.3% of physician's signature. Overall 23.9% of
prescriptions were illegible and 29.9% of prescriptions were incomplete. Legibility and completeness are
higher in unusual drugs prescriptions.
Conclusion: The Intensive Care Section performed best as far as quality of prescription writing was
concerned when compared with the Medical and Surgical Sections.
Nevertheless the overall illegibility and incompleteness (above 20%) are unacceptably high. Values need to 
be improved by enhancing the safety culture and in particular the awareness of the professionals on the 
consequences that a bad prescription writing can produce.
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Background
Adverse drug events (ADEs), usually defined as injuries
caused by the use of a drug, are a major health concern for
the patient in most clinical settings.[1]
It has been estimated that ADEs account for approxi-
mately 5% of all hospital admissions, occur during 10–
20% of hospitalisations and are responsible for 7–9% of
hospitalisation days.[2]
Some ADEs are caused by errors called medication errors
that have similar consequences as well as lowering patient
satisfaction.[3] Chart reviews of inpatients reveal that over
half of all hospital medication errors occur at the inter-
faces of care.[4]
If we consider harm caused by any error, medication error
is the fourth most frequent category among all sentinel
events collected by the Joint Commission between Janu-
ary 1995 and June 2008 after wrong site surgery, suicide
and op/post op complication.
A medication error can occur at any step of the medication
use process: prescribing, transcribing, dispensing and
administering. Prescribing and administering errors are
the two most frequent types of medication errors, but
while 48% of the former can be intercepted, only 2% of
the latter are intercepted.[5]. The reported frequency of
prescription errors varies between 39% [6] and 74% of all
medication errors [7] in specific settings. Ridley states that
almost 50% of all prescription errors in Intensive Care
Units (ICUs) are due to four categories: not writing the
order according to the formulary, ambiguous medication
order, non standard nomenclature and writing illegibil-
ity.[8]
A broad definition of prescribing error includes errors in
decision making and errors in prescription writing.[9] Pre-
scribing errors involving decision making include a wrong
choice for the patient (due to allergies, interactions
between two drugs, presence of liver or renal failure,
wrong molecule, dose or route of administration, etc.).
Prescription errors in prescription writing, instead,
involve illegibility, ambiguous abbreviations, lack of an
important piece of information such as date of prescrip-
tion, dose, route, frequency of administration, etc.[10]
Since the latter can be more easily determined and
detected through chart review, we focused our attention
on them.
The aim of this study is to analyse, as a part of a continu-
ous quality improvement program, the quality of pre-
scription writing for antibiotics, in an Italian University
Hospital. We did not analyse the appropriateness of the
molecule choice, but we evaluated the completeness and
legibility of information present in the clinical records as
risk factors for prescription errors.
Methods
The study, a point prevalence survey, took place between
26–30 May 2008 in a North-Eastern University hospital.
All 41 inpatient Units were involved, except for ophthal-
mology and dermatology since their antibiotic use, when
present, is mainly topical, an administration route not
considered in this survey.
For study purpose Units were grouped together in medi-
cal, surgical and intensive care sections, as follows:
￿ Medical section: cardiology, haematology, infectious
diseases, internal medicine, nephrology, neurology,
oncology, pediatrics, post acute care, pulmonology,
radiotherapy, rheumatology, pain control, nursery.
￿ Surgical section: general surgery, maxillofacial sur-
gery, plastic surgery, vascular surgery, heart surgery,
vertebral (spine) surgery, neurosurgery, urology, gas-
troenterology, orthopedics and traumatology, obstet-
rics, gynecology, otorhinolaryngology.
￿ Intensive Care section: anesthesia and intensive care
unit, medical intensive care unit, neonatology, coro-
nary unit.
The surveyors looked at the clinical record, both nursing
and medical data, of the inpatients present in ward at 8.00
AM on the day of the survey. In the hospital different for-
mats exist for recording drug prescriptions. A healthcare
worker (HCW) was in charge of giving information to the
surveyors in case the clinical record was not clear enough.
All antibiotic prescriptions for parenteral or oral use were
included in the survey. Every Unit was surveyed in one
single day. Patient's age, gender and number of admitted
patients were recorded. For those patients who had any
parenteral or oral antibiotic prescriptions we collected fur-
ther information: antimicrobial agent, dose, date of pre-
scription, prescriber signature, frequency of
administration, route of administration, indication for
given therapy or target for prophylaxis in medical records
and presence of microbiological culture before therapy.
When the indication was surgical prophylaxis it was spec-
ified whether it was single dose or lasting ≤ 24 h or > 24 h.
Each prescription was analysed for: legibility (generic or
trade name, dose, frequency of administration) and com-
pleteness (generic or brand name, dose, frequency of
administration, route of administration, date of prescrip-
tion and signature of the prescriber). Each item was classi-
fied as compliant when it was filled in and legible; if
partially compliant it was classified as non compliant. TheBMC Clinical Pharmacology 2009, 9:9 http://www.biomedcentral.com/1472-6904/9/9
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total completeness and legibility were calculated consid-
ering all the specific items.
The Anatomical Therapeutic Chemical (ATC) classifica-
tion system was used to class the antibiotics.
The adopted definition of completeness was "having all
necessary parts or components" while the one adopted for
legibility stated "easily readable by someone who is not
familiar with the context examined".
Eight doctors (residents in Hygiene and Preventive Medi-
cine) and 2 pharmacists performed the survey. They gave
each patient an identifying code, so that the data collected
were anonymous.
A meeting was held before starting the survey so that the
surveyors could analyse the items on the form and stand-
ardize data collection with the aim of reducing the inter
operator variability. To this end pairs of surveyors were
created to visit each ward, too.
This observational study was performed in agreement
with the local ethical committee in compliance with the
Italian law.
Data were processed using the software program SPSS ver-
sion 12.0. The statistical analysis was performed using the
Chi-Square, non parametric k-sample (Kruskal-Wallis)
and 2-sample (Mann Whitney) tests assuming as signifi-
cant a p value ≤ 0.05.
Results
Out of 756 patients included in the study, 408 antibiotic
prescriptions were found in 298 patients (mean prescrip-
tions per patient 1.4; SD ± 0.6). Overall, 39.4% of patients
used antibiotic and 92.7% (38/41) of the Units had at
least one patient with antibiotic prescription. Table 1
shows the percentage of patients with antibiotic prescrip-
tion classified by section.
Antibiotic prescriptions from the medical section were sig-
nificantly higher than prescriptions from the surgical sec-
tion (p = 0.019), whereas the mean number of
prescriptions per observed patient proved to be signifi-
cantly higher in intensive care section (p = 0.008) and
medical section (p = 0.04) compared to the surgical sec-
tion.
For 165/408 (40.4%) prescriptions the indication was
prophylaxis both medical and preoperatory; the remain-
ing 243/408 (59.6%) had a therapeutic indication.
Of the 243 therapeutic prescriptions overall 55.6%(135/
243) had a previous written request for a microbiological
culture without differences among different areas.
Written reasons for prescribing antibiotic were found in
58.1%(237/408) of the prescriptions, more frequently for
therapeutic indication 166/237 (70%) than for prophy-
laxis 71/237 (30%); in the remaining cases it was neces-
sary to request information from the medical or nursing
staff.
In medical section written reasons for using the antibiotic
were present in 65.2%(144/221) of prescriptions, in sur-
gical section in 46.2%(60/130) and in intensive care sec-
tion in 57.9%(33/57) of the cases.
Prescriptions for perioperative prophylaxis in the surgical
section were for more than 24 hours in 87.7% (79/90) of
the cases.
To obtain a global view of legibility and completeness in
the hospital antibiotic prescriptions we analysed drug
name, dose and frequency and route of administration,
prescription date and signature classified by section [see
Additional file 1].
A more detailed analysis showed that the legibility versus
illegibility of the drug's name was higher in the medical
section than in the other two sections (p = 0.003). Inten-
Table 1: Distribution of patients and prescriptions in the three areas considered.
Section 
(n. units)
% Patients with antibiotic prescription 
(patients with prescription/patient observed)
Antibiotic prescriptions 
(n.)
n. antibiotics/patient 
(Mean; Standard Deviation)
Medical Section
(16)
43,1
(155/360)
221 1,4 ± 0,7
Surgical Section
(18)
34,0
(106/312)
130 1,2 ± 0,4
Intensive Care Section
(7)
44,0
(37/84)
57 1,5 ± 0,6
Total 39,4
(298/756)
408 1,4 ± 0,6BMC Clinical Pharmacology 2009, 9:9 http://www.biomedcentral.com/1472-6904/9/9
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sive care completeness was significantly higher than the
other two as far as dose (p < 0.001), frequency of admin-
istration (p = 0.035) and prescription date (p < 0.001) are
concerned.
In the medical and intensive care sections the route of
administration was completed in a significant greater por-
tion of the prescriptions than in the surgical section (p <
0.001 and p < 0.035 respectively). Overall 23.9% of pre-
scriptions were illegible and 29.9% of prescriptions were
incomplete.
The distribution of legibility and completeness by antibi-
otic category is shown in additional file 2 [see Additional
file 2].
Discussion
The study highlights the need to pay attention to antibi-
otic prescription writing: in fact 1 in 4 prescriptions were
not fully completed or were illegible. We think this is a
field that could be improved, particularly for some items,
like dosage legibility prescription, date and physician's
signature.
We found a widespread use of antibiotics: almost all Units
(92.7%) on the day of the survey had at least one patient
with an antibiotic prescription.
This is not unusual in acute care hospitals as reported in
other studies.[11,12] Such a wide use implies also that
potential antibiotic medication errors are events to atten-
tively control and prevent.
Our study focused attention on formal quality character-
istics that is part of the medication error risk. Certainly
this risk should be evaluated hospital by hospital and,
eventually in each department or Unit, possibly adopting
proactive methods like the Health Failure Mode Effect
Analysis (HFMEA).
Nevertheless, we think that data presented in this paper
can serve to increase health care workers' awareness of
drug use safety, and specifically of written communica-
tion, i.e. how to fill in clinical documentation precisely.
Monitoring these aspects is quite simple since based on
existing clinical documentation. We performed a hospital
wide survey but this is not strictly necessary in a routine
program since a few cases per Unit would be enough to
show attitudes and behaviours of the professional teams.
If any hospital quality and safety oriented team would
adopt the same methodology it should involve some pro-
fessionals to read prescriptions: no specific training is
required but the recommendation that professionals are
different from those of the observed Units.
In fact doctors and nurses have to use this information to
decide on further clinical actions: if they are not able to
find or read and understand written prescriptions, they
can immediately realise the risks related to patient safety.
Through this methods we can detect also the use of acro-
nyms that we know are a risk factor when different profes-
sionals do not share their meaning, or worse, they are
misinterpreted.[13].
Our data show that Intensive Care Units have some char-
acteristics we should consider:
￿ patients with antibiotic prescriptions and mean
number of prescriptions per observed patient are
higher than in the other sections because of the
expected severity and typology of inpatients;
￿ they show the best performance in terms of com-
pleteness in all items, except for the signature of the
physician that remains unfulfilled. These data may
mirror the fact that the Intensive Care Units are
selected settings where the patient safety culture is
more widespread because they often have to deal with
critical situations like emergencies. The diffusion of
risk reduction strategies such as protocols or checklists
in these settings have long been appreciated and are
more frequently used in these sections.
Written reasons for antibiotic prescriptions cover approx-
imately half of the cases (58.1%), more frequently if the
indication is therapeutic. Microbiological cultures are
requested before starting the therapy in a percentage
slightly over the half as well (55.6%). In our opinion both
aspects should be improved and they must be part of a
wider quality improvement program related to antibiotic
use appropriateness.
We found that perioperatory prophylaxis lasting > 24 h
was high (87.8%) in spite of the international guidelines
recommending a short or ultra short first choice prophy-
laxis, leaving to a limited number of selected patients the
possibility to extend it over one day [14]. This finding,
however, reflects a widespread approach common to both
Italian [15] and worldwide [16] hospital settings. We did
not collect information on surgical patients case-mixes
and thus it is not possible to judge the appropriateness of
the extended perioperative prophylaxis. Further studies
could address this issue and, in our case, evaluate the best
strategies to support the adoption of existing guidelines in
future [17,18].BMC Clinical Pharmacology 2009, 9:9 http://www.biomedcentral.com/1472-6904/9/9
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Legibility and completeness are higher in unusual drugs
prescriptions.
In general, there are consistent differences in legibility and
completeness when different chemical principles are con-
cerned but we cannot compare all these percentages,
because, in the case of specific drugs (i.e. Antimycotics for
systemic use), we analysed only one hospital and the per-
formance can be influenced by a limited number of Units
prescribing that chemical principle.
Further important but simple directions that come out as
priorities from this survey are the necessity to print pre-
scriptions and the need to record the route, dose and fre-
quency of administration of the drug. The lack of
prescription date and doctor's signature were the most
critical areas in terms of prescription completeness, both
were absent in more than 50% of the prescriptions.
We think that a systematic use of feedback together with
the adoption of formats where spaces for prescription
date, signature of the physician and route of administra-
tion are more emphasised would simplify the prescriber's
task.
It is reported that computerized physician order entry and
computerised physician decision support, in fact, signifi-
cantly reduce prescription errors improving drug safety
[19]. Nevertheless, an investment in information technol-
ogy is not always feasible, at least not in the short term
particularly in those healthcare settings with economic
restraints. In these circumstances a few simple recommen-
dations to lower the prescription error rate can be
adopted, since they are useful, cheap and easy to apply:
i.e. the introduction of an integrated patient therapy
record, the standardization of the patient's record format
throughout the hospital, a high completeness and legibil-
ity of the prescription, the discouraging of verbal prescrip-
tions and, if any are given, the introduction of a read-back
procedure and finally an active involvement and educa-
tion of the patient in the current knowledge of his/her
drug therapy [20].
This study analysed only the legibility and completeness
as risk factors for prescription errors but despite this, we
think it has an operative relevance and it is essential in
improving quality of healthcare and reducing errors.
A limit of the study is that only some of the risk factors in
prescription writing can be detected through chart review,
thus for instance the potential error of omission is an
aspect that cannot be detected through this methodology
but could be considered for further studies that involve
the direct observation of the professionals.
The paper addresses an important issue of antibiotic safety
that reflects a global problem. In fact this is not only a
problem in Italy but also in other hospitals around the
world. It would be also interesting to include in a further
study numerous hospitals. The magnitude of this problem
could be even more severe in the less resourced countries
such as Africa and Asia.
The findings confirm that there is a problem that needs to
be attended to and serve to sensitise stakeholders in
health delivery about this issue.
Conclusion
The survey confirms the extensive use of antibiotics in an
acute care hospital.
Written reason for the use of an antibiotic is poor as is the
request for microbiological culture in case of therapeutic
indication.
Overall legibility is good in more than three out of four
cases, while completeness is poor mainly concerning the
date of prescription and the signature of the physician.
The feedback of the objective data to the Units is a great
opportunity to improve the awareness of safety and to
stress the need for accuracy in prescription writing. As the
measurements are objective they can be repeated to mon-
itor trends over time.
Since several easily identified risk factors are associated
with a large proportion of medication prescribing risk fac-
tors, an intervention is needed to enhance the safety cul-
ture in all settings by improving clinical documentation
and through enhanced the professional awareness of
potential medication errors related to bad prescription
writing.
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